InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Krakaris Emmanuel, Chairman & CEO. Insider active across 2 companies, notably Augmedix, Inc.. Cumulatively, 4 filings have been recorded. Total volume traded: €345k. The latest transaction was filed on 24 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€44,25415,551 shares@ €2.845725.6% of flow
Common Stock
SEC:0001213900-21-062044·
Ideal exit: 21 Aug 2022 (T+270)
€44,25415,551 shares@ €2.845712.8% of flow
Common Stock
SEC:0001213900-21-062044:0·
Ideal exit: 21 Aug 2022 (T+270)
€128,38537,500 shares@ €3.423674.4% of flow
Common Stock
SEC:0001213900-21-055925·
Ideal exit: 25 Jul 2022 (T+270)
€128,38537,500 shares@ €3.423637.2% of flow
Common Stock
SEC:0001213900-21-055925:0·
Ideal exit: 25 Jul 2022 (T+270)
4 of 4 declarations
About Krakaris Emmanuel
Emmanuel Krakaris is the Chairman & CEO and Secretary of Augmedix, Inc. He is responsible for the strategic direction of the company, ensuring its development and compliance. Emmanuel plays a key role in the innovation and enhancement of the services offered by Augmedix.
